leverage and across so many sectors short term we're advising our clients to turn elsewhere for yields pharmatech, tell kecon that being said, at some point in future there will be value. we just feel like shorter term the uncertainty is out weighing the value that would be there. i would keep a close eye on it as the world starts open and people start going back to work. where do the trends end going back to work is it really people working from home m or will or will we figur to social distance and be back at capacity in 12 to 18 months >> that being said, is there anything in real estate that you do think is attractive here? >> not right now, kelly. we have been reducing our exposure to reits and we're cautious on the sector going forward. as michael mentioned a lot of rent collection issues another thing that is interesting in the event this does get worse and there's a black swan event, a highly levered asset like this. this is part of the equity piece of the capital sort last to collect. fp you look at it from a technical point of view, you can see the low part of this chart you're seei

base with that they have hospitals and consumer, and as you imagine in the pharma company, there's a decent, free cash flow yields is roughly debt to equity around 4.4, 4.5 times and at a time when you're worried about balance sheet, this is a company that has an earnings history of consistency. so when they pull that guidance, with that business model, i have a lot of confidence that this is a company that as an investor you should be taking a medium term outlook on a lot of these companies today. why abbott in they pulled guidance, but they gave pretty decent commentary on what's going on with their diagnostics business and their devices business which was really probably the one that was most hit, they're saying, hey, look, we could be v-shaped on this, but if you think about the diagnostics business, we've heard a lot about covid and what abbott is doing on testing and some of the core other established businesses including established pharma is a business that is very consistent over the long haul. the nutrition business was probably something that was, if anything, there were some pantry stocking and a fro